Literature DB >> 503232

ADP is a potent inhibitor of human platelet plasma membrane adenylate cyclase.

D M Cooper, M Rodbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 503232     DOI： 10.1038/282517a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  16 in total

1.  Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin.

Authors:  R W Farndale; A B Winkler; B R Martin; M J Barnes
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

Review 2.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

3.  Particulate guanylate cyclase and adenylate cyclase activities after activation with various agents in rabbit platelets. An ultracytochemical study.

Authors:  A Spreca; M G Rambotti; R Donato
Journal:  Histochem J       Date:  1991-03

4.  Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.

Authors:  K A Williams; W Murphy; R J Haslam
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

Review 5.  P2 receptors: new potential players in atherosclerosis.

Authors:  Francesco Di Virgilio; Anna Solini
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

6.  2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.

Authors:  D E Macfarlane; P C Srivastava; D C Mills
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Evidence for regulation of human platelet adenylate cyclase by phosphorylation. Inhibition by ATP and guanosine 5'-[beta-thio]diphosphate occur by distinct mechanisms.

Authors:  I A Wadman; R W Farndale; B R Martin
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

8.  Platelets of pseudohypoparathyroid patients: evidence that distinct receptor-cyclase coupling proteins mediate stimulation and inhibition of adenylate cyclase.

Authors:  H J Motulsky; R J Hughes; A S Brickman; Z Farfel; H R Bourne; P A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

9.  Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.

Authors:  Wei Zhang; Robert W Colman
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

Review 10.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.